With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology
Puma Biotechnology Inc. | BioWorld
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Here's Why Puma Biotechnology, Inc. (PBYI) is Down on Tuesday
Puma Bio: A Contrarian Investment That Requires Patience (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Analysts Have Made A Financial Statement On Puma Biotechnology, Inc.'s (NASDAQ:PBYI) First-Quarter Report
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Articles with Puma Biotechnology
Puma Biotechnology Inc (PBYI): Hedge Funds Taking Some Chips Off The Table
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
Puma Biotechnology Announces Litigation Victory with Jury's Decision | Business Wire
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology (NasdaqGS:PBYI) Stock Price & Quote Analysis - Simply Wall St
Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today | The Motley Fool
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2022
Puma Biotechnology Surging
PBYI Insider Trading - PUMA BIOTECHNOLOGY Inc - SecForm4.Com
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
